Found 7 matching trials
A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer
PHASE1People with pancreatic cancer that cannot be cured by surgery are being ask...
Location
Georgetown University Medical Center
SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer
PHASE2Hypothesis: Survival benefits could be found in SBRT Plus Pembrolizumab and...
Location
Changhai hospital
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
PHASE2The current study seeks to further investigate the impact of up-front syste...
Location
UPMC Cancer Centers
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
NAThe aim of this study is to compare the safety and efficacy of SBRT in LAPC...
Location
Changhai hospital
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
PHASE2This multi-institutional trial aims to evaluate the potential benefit and s...
Location
Stanford University School of Medicine
Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
PHASE2The purpose of this study is to assess surgical conversion rate and the imm...
Location
Fourth Hospital of Hebei Medical University
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
PHASE1This study is looking at determining the maximum safe dose of CyberKnife wh...
Location
MD Anderson Cancer Center at Cooper